Lightbridge Corporation Q4 FY2025 earnings call

2025 was transformative for Lightbridge. Achieved major fuel development milestones, including beginning irradiation testing of enriched uranium zirconium alloy fuel material samples at Idaho National Laboratory. Signed MOU with Oklo Inc. to explore collaboration opportunities. Expanded scope of work at Idaho National Laboratory, beefed up in-house fuel development team. Presented three technical papers at Top Fuel 2025 Conference. Near-term priorities include recruitment, continued irradiation testing, engagement with NRC, developing co-extrusion fabrication process, site selection for Expandable Fuel Facility, thermohydraulic modeling/experiments.

Not applicable as no specific product segment financial performance details provided

Near-term priorities include recruitment of additional personnel, continued irradiation testing and post-radiation examination of coupon samples, refinement of phenomena identification and ranking table analysis and fuel qualification plan, start of engagement with US Nuclear Regulatory Commission, further development of co-extrusion fabrication process, site selection and initial deployment planning for Lightbridge Expandable Fuel Facility, thermohydraulic modeling and experiments to confirm key parameters.

Statements on call include forward-looking statements and involve certain risks and uncertainties that may cause actual results to differ significantly from estimates. These and other risks are set forth in more detail in Lightbridge's filings with the Securities and Exchange Commission.

No questions submitted for this call